Close Menu

NEW YORK – Calibre Scientific said this week that it has completed the acquisition of the NeXtal Biotechnologies line of structural biology products from Qiagen. NeXtal specializes in the production of unique screens and plates for protein crystallization, an important step in structural biology studies and structure-based drug design. NeXtal's products include a comprehensive suite of crystallization screens and proprietary EasyXtal crystallization plates that are currently sold in academic, biotechnology, and pharmaceutical markets.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.